CTOs on the Move

HepaHope

www.hepahope.com

 
HepaHope is a Irvine, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.hepahope.com
  • 30 Fairbanks Ste 110
    Irvine, CA USA 92618
  • Phone: 949.421.3600

Executives

Name Title Contact Details

Similar Companies

Inari Medical

Inari Medical is a medical device company pioneering devices for the interventional treatment of vascular thrombi and emboli.

Nevro

Nevro`s Senza system is the only SCS system capable of delivering HF10™ therapy and providing pain relief without paresthesia.

Abbott International

Abbott International is a Saint-Laurent, QC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Symmetry Surgical

Symmetry Surgical is dedicated to developing high-quality surgical instruments that respond to clinicians` needs as they arise, making a real difference in the lives of patients.   Our broad portfolio also brings together the rich history and distinctive product lines of the recently acquired stainless steel and titanium surgical instruments of Codman, the surgical instruments of Specialty Surgical Instrumentation (SSI) and the electrosurgery instruments of Olsen Medical.   Offering one of the most comprehensive suites of surgical instruments in the industry, we continue to collaborate with clinicians, global medical device manufacturers and thousands of hospitals to provide solutions for today`s needs and tomorrow`s growth.   Headquartered just outside of Nashville, TN, Symmetry Surgical is a wholly owned subsidiary of Symmetry Medical Inc.(NYSE:SMA).

Cordis

With more than a 60-year history of pioneering products to treat millions of patients, Cordis is a worldwide leader in the development and manufacturing of interventional cardiovascular technology. Cordis established a legacy of high-quality and minimally-invasive cardiovascular products; and has built a robust global footprint with operations in more than 60 countries around the world. As from August 2, 2021, Cordis is a standalone company, and is committed to investing $300 million to accelerate innovation in its broad product portfolio. Building on our storied brand, we are unleashing our potential to be a $10 billion leader bringing new technology to the market through bold action at speed.